ASCO 2024 Plenary: LAURA Trial in Unresectable Stage III EGFRm NSCLC

Season 10 Episode 35  ·  Jun 10, 2024, 07:40 PM

Headliner
Share
Subscribe

OncLive On Air partners with Two Onc Docs to bring insights on primary data from the LAURA trial, which were presented at the 2024 ASCO Annual Meeting.

Share
Subscribe
Next
Rosenberg Reviews the Evolving Role of Toripalimab in Nasopharyngeal Carcinoma
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air